Importantly, SUVmax is directly related to the Ki-67 proliferation index in DLBCL (r = 0.7, P < 0.01) [13], indicating that patients with high proliferation potential lymphoma may be particularly prone to development of adverse effects. The gene discussed is MKI67; the disease is diffuse large B-cell lymphoma.